Athersys, Inc. (ATHX)

Trade ATHX now with
4/20/2020 4:08:32 PM Athersys Announces Closing Of Public Offering Of Common Stock
4/15/2020 9:55:18 PM Athersys Prices Public Offering Of 22.25 Mln Shares At $2.25/shr
4/15/2020 4:34:43 PM Athersys Announces Proposed Public Offering Of Common Stock
4/15/2020 6:04:13 AM Athersys: FDA Authorizes Initiation Of Phase 2 Trial Of MultiStem(r) Cell Therapy In Trauma Patients
3/19/2020 6:04:43 AM Athersys Names Maia Hansen SVP, Operations And Supply Chain
2/3/2020 6:04:57 AM Athersys Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
1/15/2020 6:03:04 AM Athersys Names Ivor Macleod CFO
1/14/2020 6:09:54 AM Athersys Says One-year Results Support Positive 28-day Findings And Suggest Further Benefits For ARDS Patients
5/14/2019 6:09:32 AM Athersys Announces Fast Track Designation From FDA For MultiStem Program For Acute Respiratory Distress Syndrome
6/7/2018 6:05:23 AM Athersys Enters Agreement With HEALIOS To Expand Collaboration Into Additional Therapeutic Areas
5/10/2018 4:18:46 PM Athersys Q1 Loss/share $0.08 Vs. Loss $0.06 Year Ago
3/13/2018 4:10:59 PM Athersys Q4 Loss/share $0.11 Vs. Loss $0.10 Year Ago
3/13/2018 6:10:43 AM Athersys And HEALIOS Announce Binding LoI To Expand MultiStem Collaboration
2/2/2018 6:05:11 AM Athersys Enters New $100 Mln Equity Facility With Aspire Capital